Services
Click here for a full service list across all School of Medicine Research Cores
Radiopharmaceuticals Available for Research Use
- [18F]Sodium Fluoride – Bone tumors
- [18F]DPA-714 and [18F]FEPPA – Translocator protein (TSPO) ligand for neuroinflammation or microglia activation
- [18F]FBCTT – Dopamine transporter ligand
- [18F]Fallypride – Dopamine D2/D3 receptor radioligand
- [18F]FB-IL2 – A marker for CD25+ T-lymphocytes
- [18F]FDOPA – Neuroendocrine tumors
- [18F]FET – Primary brain tumors
- [18F]DCFPyl – Prostate Cancer – PSMA
- [18F]FAZA – Hypoxic tumor microenvironment – predictor of radiation response
- [18F]FCholine – Metastatic prostate cancer, recurrent brain tumor, hepatocellular carcinoma
- [18F]FLT- Cell proliferation, head-and-neck tumors
- [18F]FMISO – Tumor hypoxia status
- [18F]FPIA –Aberrant lipid metabolism and cancer detection
- [18F]FEOBV – Vesicular acetyl choline transporter tracer
- [11C]Carfentanil – Mu (μ) opioid receptor
- [11C]Choline – Metastatic prostate cancer, recurrent brain tumor, hepatocellular carcinoma
- [11C]Methionine – Monitoring radiation therapy of cancer